Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Foot And Mouth Disease Vaccine Market Revenue Growth On Track For A 10.1% CAGR Through 2030
The foot and mouth disease vaccine market has experienced robust expansion in recent years. It is projected to grow from $2.83 billion in 2025 to $3.11 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. The market’s past growth can be attributed to several factors, including frequent outbreaks of foot-and-mouth disease, an increasing livestock population, government-led vaccination programs, advancements in conventional vaccine technologies, and a rising awareness of animal health management.
The foot and mouth disease vaccine market size is forecast to experience rapid expansion in the coming years. It is predicted to grow to $4.57 billion in 2030, achieving a compound annual growth rate (CAGR) of 10.1%. This growth during the forecast period is attributable to the development of rapid response and DIVA vaccines, an increase in multi-species vaccination coverage, the adoption of oil-adjuvanted and aluminum hydroxide-based vaccines, augmented government funding for FMD control, and rising investments in cold chain and distribution infrastructure. Significant trends expected during this period include a greater uptake of emergency vaccines for rapid outbreak response, an intensified focus on multi-species FMD vaccination programs, the creation of DIVA (differentiating infected from vaccinated animals) vaccines, the expansion of government-led immunization campaigns, and the increasing use of oil-adjuvanted and aluminum hydroxide-based vaccines.
Get A Free Sample Report With In-Depth Market Insights:
Foot And Mouth Disease Vaccine Market Growth Factors: What’s Supporting Expansion?
The expanding population of livestock is a primary catalyst propelling the Foot And Mouth Disease Vaccine Market. Livestock encompasses farm animals such as cows, horses, and pigs, which are housed, raised, and utilized by humans. The increase in the livestock population stems from a heightened demand for animal products. As livestock numbers grow, so does the likelihood of Foot and Mouth Disease prevalence, which in turn fuels market expansion. For instance, in July 2023, the FAO, a US-based United Nations agency, projected that global milk production in 2023 was set to increase to 944 million tonnes, representing a 0.9% rise from 2022. This forecast reflected a growing demand for animal-source foods, influenced by increasing incomes and a dietary shift towards protein. Consequently, the rising livestock population is expected to drive the Foot And Mouth Disease Vaccine Market. The projected growth of the Foot And Mouth Disease Vaccine Market is also anticipated to be propelled by an increase in healthcare expenditure. Healthcare expenditure refers to the total funds allocated to healthcare goods and services within a defined timeframe. This spending is vital for supporting research and development endeavors in the field of veterinary medicine. Such funding contributes to the creation of more effective and advanced vaccines, including those specifically designed to prevent foot and mouth disease in animals. As an example, the Organisation for Economic Co-operation and Development (OECD), a France-based intergovernmental economic organization, noted in November 2025 that healthcare systems in its member countries allocated an average of 9.3% of GDP to health in 2024. This demonstrated renewed growth in real per capita spending after a period of stagnation in 2023, with average spending per person rebounding to above 3% annual growth. Therefore, the rise in healthcare expenditure is a significant factor driving the Foot And Mouth Disease Vaccine Market’s expansion.
Foot And Mouth Disease Vaccine Market Segment Breakdown: Which Categories Lead On Revenue?
The foot and mouth disease vaccine market covered in this report is segmented –
1) By Vaccine Type: Conventional Vaccines, Oil Based Vaccines, Aluminum Hydroxide Or Saponin Based Vaccines, Emergency Vaccines
2) By Animal Type: Cattle, Pig, Sheep And Goat, Other Animals
3) By Distribution Channel: Government Organizations, Distributors Or Pharmacies, Private Vet, Other Distribution Channels
Subsegments:
1) By Conventional Vaccines: Inactivated Whole Virus Vaccines, Live Attenuated Vaccines, Oil-Based Vaccines
2) By Oil-Based Vaccines: Oil Emulsion Vaccines, Oil Adjuvanted Vaccines, Aluminum Hydroxide OrSaponin Based Vaccines
3) By Aluminum Hydroxide Or Saponin Based Vaccines: Aluminum Hydroxide Adjuvanted Vaccines, Saponin Adjuvanted Vaccines
4) By Emergency Vaccines: DIVA (Differentiating Infected From Vaccinated Animals) Vaccines, Rapid Response Vaccines
Foot And Mouth Disease Vaccine Market Industry Trends: What’s Reshaping Demand?
Leading businesses within the foot and mouth disease vaccine market are introducing novel offerings, including clinical phases, aimed at enhancing their market profitability. These trials involve scientific investigations designed to evaluate emerging treatments and pharmaceutical products. As an illustration, in June 2023, the Department of Animal Husbandry and Dairying, an Indian ministry, initiated the 3rd Phase of FMD Vaccination as part of the NADCP. This third phase of the NADCP’s FMD vaccination initiative represents a comprehensive effort to combat Foot and Mouth Disease in livestock and forms part of an overarching strategy to control FMD through vaccination by 2025, with ultimate eradication targeted for 2030. The success of this endeavor is crucial for boosting domestic production and increasing exports of milk and animal products.
Foot And Mouth Disease Vaccine Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the foot and mouth disease vaccine market are Godrej Agrovet Limited, Biogénesis Bagó S.A., Indian Immunologicals Limited, Merck & Co. Inc., Intervet India Private Limited, China Animal Husbandry Group, C.H. Boehringer Sohn AG & Co. KG, FGBI-ARRIAH, NAVETCO NATIONAL VETERINARY JOINT STOCK COMPANY, Ceva Santé Animale, Alivira Animal Health Limited, Zoetis Inc., Dong Bang Co. Ltd., The Spirit Jinyu Biological Pharmaceutical Co. Ltd., Biovet Private Limited, MEVAC, SPIC Gene Science Technology Development Co. Ltd., VETAL Animal Health Products Inc., Southern Cross Group, VECOL S.A, Limor de Colombia
View The Full Foot And Mouth Disease Vaccine Market Report:
Foot And Mouth Disease Vaccine Market Geographic Landscape: Which Region Leads Industry Growth?
Asia-Pacific was the largest region in the foot and mouth disease vaccine market in 2025. The regions covered in the foot and mouth disease vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
